Schizophrenia

Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual Experience

Summary: 

-- New Outcomes Research Analyzed Patterns of Weight Gain and Treatment Interruptions Associated With the Use of Second-Generation Oral Antipsychotics in Patients With Schizophrenia or Bipolar I Disorder --

-- Five Additional Poster Presentations Highlight Data Related to ALKS 3831 and ARISTADA® --

Press Release

-- New Outcomes Research Analyzed Patterns of Weight Gain and Treatment Interruptions Associated With the Use of Second-Generation Oral Antipsychotics in Patients With Schizophrenia or Bipolar I Disorder --

-- Five Additional Poster Presentations Highlight Data Related to ALKS 3831 and ARISTADA® --

Alkermes: Supporting Our Patients During COVID-19

Multimedia with summary

While the COVID-19 pandemic has created so much uncertainty, we remain committed to supporting people living with substance use disorders and schizophrenia and helping to assure that patients have access to our medicines.

Read more here

Sanofi – For Better Mental Health Care in Madagascar

Multimedia with summary

Sanofi has launched in 2008 in Madagascar a training programme for healthcare professionals to help for a better mental health care.

Smoking and Schizophrenia Linked by Alterations in Brain Nicotine Signals

Reports new study in Biological Psychiatry
Press Release

Philadelphia, PA, September 16, 2014 /3BL Media/ – Schizophrenia is associated with increased rates and intensity of tobacco smoking.  A growing body of research suggests that the relationship between schizophrenia and smoking stems, in part, from an effort by patients to use nicotine to self-medicate symptoms and cognitive impairment associated with the disease.

“Noisy” Memory in Schizophrenia

Press Release

Philadelphia, PA, July 14, 2014 /3BL Media/ – The inability to ignore irrelevant stimuli underlies the impaired working memory and cognition often experienced by individuals diagnosed with schizophrenia, reports a new study in the current issue of Biological Psychiatry.

Gathering the Clues to Rare Gene Variants Contributing To Schizophrenia

Findings from two new studies in Biological Psychiatry
Press Release

Philadelphia, PA, February 20, 2014 /3BL Media/ – Schizophrenia has long been known to be highly heritable and is present in approximately 1% of the population. Researchers have been following two paths in their pursuit of identifying schizophrenia risk genes.

Initially, they studied common gene variants that, individually, only increase the risk for schizophrenia by a few percent, perhaps increasing the likelihood of developing schizophrenia from a 10 out of a 1000 chance to an 11 or 12 out of a 1000 chance.

Calculating the Value of Effortful Behavior: A Clue to Schizophrenia-Related Disability?

From a new study in Biological Psychiatry
Press Release

Philadelphia, Pa., July 10, 2013 /3BL Media/ – Many people with schizophrenia have marked problems with motivation, failing to initiate and persist in goal-directed behavior. These negative symptoms of schizophrenia can be disabling and prevent individuals from realizing their potential.

Google Searches about Mental Illness Follow Seasonal Patterns

New study in the American Journal of Preventive Medicine reports
Press Release

SAN DIEGO, Cailf., April 9, 2013 /3BL Media/ – A new study published in the May issue of the American Journal of Preventive Medicine finds that Google searches for information across all major mental illnesses and problems followed seasonal patterns, suggesting mental illness may be more strongly linked with seasonal patterns than previously thought.

Schizophrenia: A Disorder of Neurodevelopment and Accelerated Aging?

Suggests a new study in Biological Psychiatry
Press Release

Philadelphia, PA, March 6, 2013 /3BL Media/ – Many lines of evidence indicate that schizophrenia is a disorder of neurodevelopment. For example, genes implicated in the heritable risk for schizophrenia are also implicated in the development of nerve cells and their connections. Numerous findings in brain imaging studies describe the changes in brain structure and function associated with schizophrenia as emerging early in the course of the disorder. Some early brain imaging studies even found little or no evidence of progression of structural deficits.

Subscribe to Schizophrenia